RAC1 and hepatocellular carcinoma: The expression of RAC1, a known target of miR-142-3p [25], was significantly down-regulated in the HCC cells following incubation with TAMs from the propofol-treated HCC tissue (Figure 2C and 2D), suggesting that the level of functional miR-142-3p levels increased in the HCC cells.